Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dean M Wingerchuk

Showing results (1-10 of 184) with videos related to

Pageof 19
Sort By:
International Review of Neurobiology|May 29, 2007
Neuromyelitis optica: new findings on pathogenesisDean M Wingerchuk
Advances in Neurology|January 13, 2006
Neuromyelitis opticaDean M Wingerchuk
Journal of the Neurological Sciences|September 11, 2009
Neuromyelitis optica: effect of genderDean M Wingerchuk
Neurological Research|May 12, 2006
Evidence for humoral autoimmunity in neuromyelitis opticaDean M Wingerchuk
Journal of Clinical Immunology|September 15, 2012
Neuromyelitis optica: potential roles for intravenous immunoglobulinDean M Wingerchuk
Current Neurology and Neuroscience Reports|April 15, 2003
Postinfectious encephalomyelitisDean M Wingerchuk
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 23, 2019
Disease-modifying therapies should be stopped in NMOSD patients in remission - CommentaryDean M Wingerchuk
The Mount Sinai Journal of Medicine, New York|March 23, 2011
Environmental factors in multiple sclerosis: Epstein-Barr virus, vitamin D, and cigarette smokingDean M Wingerchuk
Continuum (Minneapolis, Minn.)|July 20, 2012
Neuromyelitis optica spectrum disordersDean M Wingerchuk
Expert Review of Neurotherapeutics|March 15, 2006
Multiple sclerosis disease-modifying therapies: adverse effect surveillance and managementDean M Wingerchuk
Pageof 19

Showing results (1-10 of 184) with videos related to

Sort By:
Pageof 19
International Review of Neurobiology|May 29, 2007
Neuromyelitis optica: new findings on pathogenesisDean M Wingerchuk
Advances in Neurology|January 13, 2006
Neuromyelitis opticaDean M Wingerchuk
Journal of the Neurological Sciences|September 11, 2009
Neuromyelitis optica: effect of genderDean M Wingerchuk
Neurological Research|May 12, 2006
Evidence for humoral autoimmunity in neuromyelitis opticaDean M Wingerchuk
Journal of Clinical Immunology|September 15, 2012
Neuromyelitis optica: potential roles for intravenous immunoglobulinDean M Wingerchuk
Current Neurology and Neuroscience Reports|April 15, 2003
Postinfectious encephalomyelitisDean M Wingerchuk
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 23, 2019
Disease-modifying therapies should be stopped in NMOSD patients in remission - CommentaryDean M Wingerchuk
The Mount Sinai Journal of Medicine, New York|March 23, 2011
Environmental factors in multiple sclerosis: Epstein-Barr virus, vitamin D, and cigarette smokingDean M Wingerchuk
Continuum (Minneapolis, Minn.)|July 20, 2012
Neuromyelitis optica spectrum disordersDean M Wingerchuk
Expert Review of Neurotherapeutics|March 15, 2006
Multiple sclerosis disease-modifying therapies: adverse effect surveillance and managementDean M Wingerchuk
Pageof 19